|
Press Releases |
|
 |
|
Wednesday, July 16, 2025 |
|
A New Chapter Begins! CMS Achieves Secondary Listing on the Singapore Exchange Main Board Today |
more info >> |
|
A New Chapter Begins! CMS Achieves Secondary Listing on the Singapore Exchange Main Board Today |
On the morning of 15 July 2025, China Medical System Holdings Limited ("CMS" or the "Group") rang the ceremonial bell to mark its official listing on the Singapore Exchange Main Board (Stock Abbreviation: CMS, Stock Code: 8A8). more info >> |
|
Wednesday, June 25, 2025 |
|
China Medical System Holdings Limited: Proposed Secondary Listing on the Singapore Exchange |
more info >> |
|
China Medical System Holdings Limited: Proposed Secondary Listing on the Singapore Exchange |
more info >> |
|
Friday, March 21, 2025 |
|
China Medical System (00867) Released its 2024 Annual Results: Focusing on Innovation and Specialty Breakthroughs to Reshape Growth Momentum |
On March 17, China Medical System Holdings Limited ("CMS" or the "Company") released its 2024 annual results. The Company recorded a turnover of RMB7,469 million, representing a year-on-year decrease of 6.8%; in the case that all medicines were directly sold by the Company, the turnover would be RMB8,622 million, representing a year-on-year decrease of 9.0%. more info >> |
|
Friday, February 14, 2025 |
|
China Medical System (867.HK) is Included in the S&P Global Sustainability Yearbook 2025 |
more info >> |
|
China Medical System (867.HK) is Included in the S&P Global Sustainability Yearbook 2025 |
In February 11th 2025, with a Corporate Sustainability Assessment (CSA) score of 61, surpassing 93% of global peers, China Medical System Holdings Limited ("CMS" or the "Group") has been included in the S&P Global Sustainability Yearbook 2025 (the "Yearbook 2025"). more info >> |
|
Friday, January 24, 2025 |
|
China Medical System (00867) Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Ra Monoclonal Antibody MG-K10 |
more info >> |
|
China Medical System (00867) Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Ra Monoclonal Antibody MG-K10 |
China Medical System (00867) Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Ra Monoclonal Antibody MG-K10 more info >> |
|
Thursday, January 9, 2025 |
|
China Medical System (00867) Obtained New Drug ZUNVEYL for the Treatment of Mild-to-Moderate Dementia of the Alzheimer's Type |
China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on 8 January 2025, the Group through a wholly-owned subsidiary of the Company entered into a License, Collaboration and Distribution Agreement (the "Agreement") with Alpha Cognition Inc. ("Alpha") of the improved new drug ZUNVEYL (benzgalantamine delayed-release tablets)("ZUNVEY" or the "Product") for the treatment of mild-to-moderate dementia of the Alzheimer's type. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
EUDR Solution From Source Intelligence Simplifies Deforestation Due Diligence
Jul 22, 2025 00:00 HKT/SGT
|
|
|
Sapient Intelligence Open-Sources Hierarchical Reasoning Model, a Brain-Inspired Architecture that Solves Complex Reasoning Tasks with 27 Million Parameters
Jul 21, 2025 22:00 JST
|
|
|
Spacely AI 獲得 100 萬美元種子輪融資,加速為全球建築師打造生成式 AI 設計能力
Jul 21, 2025 20:30 HKT/SGT
|
|
|
Spacely AI 获得 100 万美元种子轮融资,加速为全球建筑师打造生成式 AI 设计能力
Jul 21, 2025 20:30 HKT/SGT
|
|
|
Spacely AI Secures US $1 Million Seed Round to Supercharge Generative AI Design for Architects Worldwide
Jul 21, 2025 20:30 HKT/SGT
|
|
|
CMS Collaborates with SGX to Explore New Paradigms for Industrial Globalization and Pharmaceutical Expansion Overseas across Emerging Markets
Jul 21, 2025 20:20 HKT/SGT
|
|
|
Professor Emeritus Doug Hargreaves AM to Join GMG's Technical Advisory Committee Additions
Jul 21, 2025 19:39 HKT/SGT
|
|
|
sureWin Wins Prestigious Honesty Award 2025 - A Testament to Trust in Online Gaming
Jul 21, 2025 17:30: JST
|
|
|
sureWin Wins Prestigious Honesty Award 2025 - A Testament to Trust in Online Gaming
Jul 21, 2025 17:30 HKT/SGT
|
|
|
S.BIOMEDICS Cell Therapy for Parkinson's Disease Shows Positive Data from Its Phase 1/2a Clinical Trial
Jul 21, 2025 17:00: JST
|
|
|
S.BIOMEDICS Cell Therapy for Parkinson's Disease Shows Positive Data from Its Phase 1/2a Clinical Trial
Jul 21, 2025 17:00 HKT/SGT
|
|
|
AI+固收:第四范式稳定币又一动作 发布「稳定币底层资产管理解决方案」
Jul 21, 2025 16:26 HKT/SGT
|
|
|
AI+固收:第四範式穩定幣又一動作 發佈「穩定幣底層資產管理解決方案」
Jul 21, 2025 16:09 HKT/SGT
|
|
|
31 Concept 脫離隱密模式,將在 2025 年亞洲資訊安全高峰會(ISS Asia)推出突破性網路智慧平台
Jul 21, 2025 14:13 HKT/SGT
|
|
|
31 Concept 脱离隐秘模式,将在 2025 年亚洲信息安全峰会(ISS Asia)推出突破性网络智能平台
Jul 21, 2025 14:13 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|